Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,400 public trials 1,995 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, not recruiting

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

NCT06680921

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • The First Affiliated Hispital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hispital of Anhui Medical University Hefei, Anhui, China
  • Maanshan People's Hospital Maanshan, Anhui, China
View all 57 locations
View Trial Details
Active, not recruiting

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

NCT05952557

Conditions
Breast Cancer, Early Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Dothan, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Fayetteville, Arkansas, United States
View all 661 locations
View Trial Details
Active, not recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

NCT02311933

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +9 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 559 locations
View Trial Details
Active, not recruiting

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

NCT05721248

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Mayo Clinic Hospital Arizona Phoenix, Arizona, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Mayo Clinical Hospital Florida Jacksonville, Florida, United States
  • Dana-Farber Cancer Insitute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions